Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD
Study
Inclusion/Exclusion Baseline
Description Intervention
Criteria/Population Measures Outcomes
Author:
Inclusion criteria: Child problem Child problem
Sofronoff et al., Intervention:
• NR
behaviors: behaviors:
2002
Parent Management Exclusion criteria: Number of reported Number of
Country: Training (PMT)
• NR
problem behaviors reported problem
Australia Workshop: attended a 1-
by graphical behaviors by
day workshop
Age, mean/years (range): illustration only graphical
Practice Individual: Six weekly G1: 8.25 (6-12)
illustration only
setting:
sessions
Parental self-
Academic Both groups followed Gender:
efficacy, mean ± Main effect for
Intervention
manual with six
NR
components (1 hour each)
SD:
G1:
Time (F=16.98, P
< 0.0001)
setting:
including
Race/ethnicity:
Combined: 2.89 ±
Clinic
Enrollment
psychoeducation, comic NR
strip conversations (Gray,
0.84
G1a: 3.03 ± 0.79
Significant
reduction in
period:
1994a), social stories SES:
G1b: 2.75 ± 0.88 problem
NR
Funding:
(Gray, 1994b),
management of behavior
Maternal education: NR
Household income: NR G2:
behaviors
between T1 & T2
NR
problems, management of
Combined: 2.79 ± (P < 0.001) for
Author industry rigid behaviors, routines, Diagnostic approach: 0.9
both G1 & G2 &
relationship and special interests, and In Study (method): G2a: 2.61 ± 0.95 T1 & T3 (P <
disclosures: anxiety management DSM-IV criteria; diagnosis G2b: 2.97 ± 0.83 0.002)
NR
Design: Groups:
of Asperger syndrome by
pediatrician and
G3:
No significant
difference
Prospective cohort G1: Workshop
psychologist at clinic site Combined: 3.23 ± between G1 & G2
study
G2: Individual
0.89
Significant time X
G3: Wait-list
Diagnostic category: G3a: 3.21 ± 1.13 group interaction
NR
G3b: 3.25 ± 0.62 (F=8.28, P <
0.001)
Note: see related
paper with
overlapping
participants,
Sofronoff 2004
{#814}
Sofronoff et al.,
2002 (continued)
Assessment:
ECBI (Eyeberg Child
behavior Inventory)
Parental self-efficacy
Questionnaire
Used at 3 time points,
pre-intervention (T1), 4
weeks Post (T2) and 3
months follow-up (T3)
Provider:
• Clinical psychologist
Measure of treatment
fidelity reported:
No
Co-interventions held
stable during treatment:
NR
Concomitant therapies:
NR
N at enrollment:
G1a: 17 mothers
Other characteristics:
NR
C-384
Parental selfefficacy,
mean ±
SD:
Time 3:
G1:
Combined: 3.26 ±
0.77
G1a: 3.78 ± 0.42
G1b: 2.94 ± 0.79
G1a & G1b
significantly
different from T1
(P < 0.05)
G2:
Combined: 3.47 ±
0.67
G2a: 3.65 ± 0.76
G2b: 3.29 ± 0.58
G1a & G1b
significantly
different from T1
(P < 0.05)
G3:
Combined: NR
G3a: NR
G3b: NR
Harms:
NR